Ocular Development and Refractive Error Changes Among Children and Adolescent - A Longitudinal Study
NCT ID: NCT03589937
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
7050 participants
OBSERVATIONAL
2018-07-20
2024-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Pathological Changes of High Myopia Among Children and Adolescents in China
NCT03533647
Efficacy and Safety of the New Defocus Spectacle Lens in Preventing Progression of Myopia
NCT05740904
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NCT05818033
Effect of Using Myopia Prediction Algorithm on Myopia School-aged Children
NCT04045951
Age and Refraction in Predicting Myopia Progression in COVID-19
NCT05305274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No allergy to tropicamide or topical anesthetics
* written informed consent is obtained from guardian
* Be willing to cooperate with the relevant ophthalmological examination and complete the questionnaire.
Exclusion Criteria
* Receiving or has been received treatment of myopia control such as atropine eye drops, corneal contact lens or myopic glasses
* A history of allergy to topic amide or topical anesthetics
* Have severe systemic disease
* Missing ability to give informed consent
3 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongshan Ophthalmic Center, Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yizhi Liu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yizhi LIU, PhD
Role: PRINCIPAL_INVESTIGATOR
Zhongshan Ophthalmic Center, Sun Yat-san University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zengcheng
Guangzhou, Guangdong, China
Zengcheng
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYSU-OPH-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.